Lista de obras - Matteo Lazzeroni - Dominio Público Uruguay

A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast

artículo científico publicado en 2022

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

artículo científico publicado en 2017

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.

artículo científico publicado en 2015

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

artículo científico publicado en 2016

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

article published in 2013

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

artículo científico publicado en 2013

Acceptability of chemoprevention trials in high-risk subjects.

artículo científico publicado en 2013

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.

artículo científico publicado en 2017

Alternate dosing schedules for cancer chemopreventive agents

artículo científico publicado en 2015

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

artículo científico publicado en 2013

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.

artículo científico publicado en 2016

Breast cancer prevention by antihormones and other drugs: where do we stand?

artículo científico publicado en 2013

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.

artículo científico publicado en 2014

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

artículo científico publicado en 2012

Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches

artículo científico publicado en 2015

Circulating and tissue biomarkers in early-stage non-small cell lung cancer

artículo científico publicado en 2017

Correction: Effect of Low-Dose Tamoxifen on Steroid Receptor Coactivator 3/Amplified in Breast Cancer 1 in Normal and Malignant Human Breast Tissue

Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue

artículo científico publicado en 2020

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

artículo científico publicado en 2014

Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

scientific article published on 04 September 2007

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

artículo científico publicado en 2012

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series

artículo científico publicado en 2019

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years

artículo científico publicado en 2009

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

artículo científico publicado en 2015

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

artículo científico publicado en 2013

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

artículo científico publicado en 2010

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

artículo científico publicado en 2010

Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast

artículo científico publicado en 2019

Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial

artículo científico publicado en 2011

Long-term effects of inhaled budesonide on screening-detected lung nodules.

artículo científico publicado en 2015

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

artículo científico publicado en 2009

Metformin: risk-benefit profile with a focus on cancer

artículo científico

Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.

artículo científico publicado en 2012

Potential use of vaccines in the primary prevention of breast cancer in high-risk patients

artículo científico publicado en 2012

Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast

scientific article published on 10 January 2020

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

artículo científico publicado en 2011

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

artículo científico publicado en 2019

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

scientific article published on 11 April 2019

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users

artículo científico publicado en 2007

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

artículo científico publicado en 2010

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

artículo científico publicado en 2015

Synthetic retinoid fenretinide in breast cancer chemoprevention

artículo científico publicado en 2007

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

artículo científico publicado en 2013

The effect of metformin on apoptosis in a breast cancer presurgical trial.

artículo científico publicado en 2013

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

artículo científico publicado en 2017

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis

scientific article published on 09 January 2019

The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it.

artículo científico

Lista de obras de Matteo Lazzeroni

A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast

A Presurgical Study of Lecithin Formulation of Green Tea Extract in Women with Early Breast Cancer

A Presurgical Study of Oral Silybin-Phosphatidylcholine in Patients with Early Breast Cancer.

A Randomized, Placebo-Controlled, Phase II, Presurgical Biomarker Trial of Celecoxib Versus Exemestane in Postmenopausal Breast Cancer Patients

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer

Acceptability of chemoprevention trials in high-risk subjects.

Adjuvant therapy in patients with ductal carcinoma in situ of the breast: The Pandora's box.

Alternate dosing schedules for cancer chemopreventive agents

Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials

Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.

Breast cancer prevention by antihormones and other drugs: where do we stand?

Breast conservative surgery for well-differentiated ductal intraepithelial neoplasia: Risk factors for ipsilateral breast tumor recurrence.

Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

Cancer chemoprevention: Much has been done, but there is still much to do. State of the art and possible new approaches

Circulating and tissue biomarkers in early-stage non-small cell lung cancer

Correction: Effect of Low-Dose Tamoxifen on Steroid Receptor Coactivator 3/Amplified in Breast Cancer 1 in Normal and Malignant Human Breast Tissue

Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue

Differential effects of metformin on breast cancer proliferation according to markers of insulin resistance and tumor subtype in a randomized presurgical trial.

Does tamoxifen prophylaxis for breast cancer provide long-term prevention?

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial

Ductal carcinoma in situ and intraoperative partial breast irradiation: Who are the best candidates? Long-term outcome of a single institution series

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years

Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS or pre-invasive disease of the breast

Lapatinib activity in premalignant lesions and HER-2-positive cancer of the breast in a randomized, placebo-controlled presurgical trial

Long-term effects of inhaled budesonide on screening-detected lung nodules.

Low-dose tamoxifen in the treatment of breast ductal intraepithelial neoplasia: results of a large observational study.

Metformin: risk-benefit profile with a focus on cancer

Oral low dose and topical tamoxifen for breast cancer prevention: modern approaches for an old drug.

Potential use of vaccines in the primary prevention of breast cancer in high-risk patients

Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast

Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.

Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ.

Synthetic retinoid fenretinide in breast cancer chemoprevention

Tailoring treatment for ductal intraepithelial neoplasia of the breast according to Ki-67 and molecular phenotype

The effect of metformin on apoptosis in a breast cancer presurgical trial.

The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast.

The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis

The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it.